Key result
First report of malignant hyperthermia in the Indian subcontinent highlights concerning regional dantrolene unavailability.
Why the study?
Malignant hyperthermia was thought not to exist in the Indian subcontinent, leading to the non-availability of dantrolene.
Population
First reported case of malignant hyperthermia from the Indian subcontinent
Design
Case report
Loading...
May signal underrecognized malignant hyperthermia risk in the Indian subcontinent; leaves open questions on dantrolene access and regional incidence.
Highlights the emergence of malignant hyperthermia in the Indian subcontinent and the critical need for dantrolene availability.
A 2001 study studied this question. Malignant hyperthermia was reported for the first time in the Indian subcontinent, highlighting the concerning non-availability of dantrolene in this region.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: